Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Obelix who wrote (355)	4/3/1998 2:12:00 AM
From: doctor bob	Respond to of 1185

Short position as of March 19 76,500, I feel for them, but they should have done a little more research. CCM on the other hand understands the potential here, it's a pretty safe bet they won't be selling any stock. Momentum should continue, hopefully, with a big jump following a licensing deal with a major pharma. I believe a listing on the TSE will follow.

To: Obelix who wrote (355)	4/3/1998 8:41:00 AM
From: Jon Smith	Read Replies (1) \| Respond to of 1185

Recently I posed that same question to Nortran, their answer was "of course at some point they would like to move to a larger exchange as the company grows, but as for now they have no concrete plans to move to another exchange". Past posts on this thread expect NRT to go to either theTSE or AMEX. Personally I believe the new CEO would be able to use his connections and put NRT on the TSE in a heartbeat. For all we know this could already be in the works and the company is just downplaying in light of their recent price increase. The question in my mind is not if, but when and who will be the sponsor. Jon